Skip to main content
Vivimed Labs Ltd. logo

Vivimed Labs Ltd. — Investor Relations & Filings

Ticker · VIVIMEDLAB ISIN · INE526G01021 LEI · 335800LYN9TN3F87WV86 BSE.NS Manufacturing
Open in API
Filings indexed 860 across all filing types
Latest filing 2026-02-02 Board/Management Inform…
Country IN India
Listing BSE.NS VIVIMEDLAB

About Vivimed Labs Ltd.

http://www.vivimedlabs.com/

Vivimed Labs Ltd. specializes in the development and manufacture of active pharmaceutical ingredients (APIs), finished dosage formulations (FDF), and specialty chemicals. The company provides contract research and manufacturing services (CRAMS) and produces generic medicines across various therapeutic areas. Its specialty chemicals division focuses on niche products, including photochromic dyes for ophthalmic lenses, hair colorants, and anti-microbial agents for personal care and industrial use. Vivimed operates research and development centers and manufacturing facilities that adhere to international regulatory standards, catering to a global customer base in the healthcare and chemical sectors.

Recent filings

Filing Released Lang Actions
Board Meeting — Financial Results
Board/Management Information Classification · 95% confidence The document is a notice of a Board Meeting scheduled to consider and approve unaudited financial results for a quarter and nine months ending December 31, 2025. It is addressed to stock exchanges and references Regulation 29 of SEBI (Listing Obligations & Disclosure Requirements), 2015, which pertains to disclosures about board meetings. The document does not contain the financial results themselves but is a notification of the meeting where such results will be considered. The document length is short (1309 characters), and it serves as an announcement rather than a report. Therefore, it fits the category of Board/Management Information (MANG), which includes announcements of board meetings and related management information.
2026-02-02 English
Vivimed Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 ,inter alia, to consider and approve 31st december 2025 results
Regulatory Filings
2026-02-02 English
General Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the company secretary of Vivimed Labs Limited, dated January 6, 2026. It provides an update on the status of requests for re-lodgement of transfer requests of physical shares under a SEBI circular. The content is an official notification about shareholder transfer requests and processing times, intended for information and intimation to stock exchanges. The document is short (1375 characters) and does not contain financial data, audit information, or detailed report content. It is an announcement related to regulatory compliance and shareholder matters but does not fit into categories like Annual Report, Earnings Release, or Management Reports. It is not a voting result, board change, or capital update. Given the nature and length, it best fits the category of Regulatory Filings (RNS), which is a fallback for miscellaneous regulatory announcements that do not fit other categories.
2026-01-13 English
Re-lodgment of transfer requests for physical shares
Regulatory Filings
2026-01-13 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, confirming compliance actions related to dematerialization of securities for a specific quarter (01/10/2025 to 31/12/2025). It is a compliance certification letter from a compliance officer, not a financial report or announcement of financial results. The document length is short (1208 characters) and it primarily serves as an attestation of regulatory compliance rather than containing financial data or report content. Therefore, it fits the criteria for Regulatory Filings (RNS) as it is a certification letter related to regulatory compliance.
2026-01-07 English
regulation 74(5)
Regulatory Filings
2026-01-07 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.